Targeting Progesterone Receptor Membrane Component 1 to Improve Muscle Development and Glucose Homeostasis
These findings identify skeletal muscle PGRMC1 as a pivotal regulator of glucose metabolism and highlight its inhibition as a promising muscle-targeted therapeutic approach for T2D management.
Authors
- In‐Jeoung Baek (ORCID: https://orcid.org/0000-0002-0641-7208)
- Young Hoon Sung (ORCID: https://orcid.org/0000-0002-1508-9883)
- Moeka Mukae (ORCID: https://orcid.org/0009-0007-6541-9936)
- Globinna Kim
- Eui‐Ju Hong (ORCID: https://orcid.org/0000-0001-9640-8841)
- Tae‐Won Kim (ORCID: https://orcid.org/0000-0002-5239-3833)
- Sang R. Lee (ORCID: https://orcid.org/0000-0002-5809-9854)
- Jungeun Park (ORCID: https://orcid.org/0000-0002-1129-5495)
- Young Suk Won
- Hyo‐Jung Kwun
Institutions
- Chungnam National University (KR)
- University of Ulsan (KR)
- Dong-A University (KR)
- Korea Research Institute of Bioscience and Biotechnology (KR)
Publication Details
- Journal
- Journal of Cachexia Sarcopenia and Muscle
- Published
- 2025-11-10
- DOI
- https://doi.org/10.1002/jcsm.70121
- Primary Topic
- Metabolism, Diabetes, and Cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Research Foundation
- National Research Foundation of Korea
- Ministry of Science and ICT, South Korea